Dupilumab and tezepelumab in severe refractory asthma: new opportunities

Ragnoli, B; Morjaria, J; Pignatti, P; Montuschi, P; Barbieri, M; Mondini, L; Ruggero, L; Trotta, L; Malerba, M

Malerba, M (通讯作者),Univ Piemonte Orientale, Dept Translat Med, I-28100 Novara, Italy.;Malerba, M (通讯作者),S Andrea Hosp, Resp Unit, Vercelli, Italy.

THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2022; 13 ():

Abstract

Bronchial asthma is a chronic inflammatory condition with increasing prevalence worldwide that may present as heterogeneous phenotypes defined by the ......

Full Text Link